Institution
University of Fukui
Education•Fukui-shi, Japan•
About: University of Fukui is a education organization based out in Fukui-shi, Japan. It is known for research contribution in the topics: Gyrotron & Terahertz radiation. The organization has 4913 authors who have published 8971 publications receiving 129701 citations. The organization is also known as: Fukui Daigaku.
Topics: Gyrotron, Terahertz radiation, Laser, Population, Polymerization
Papers published on a yearly basis
Papers
More filters
••
TL;DR: A new method, called Majority Weighted Minority Oversampling TEchnique (MWMOTE), is presented for efficiently handling imbalanced learning problems and is better than or comparable with some other existing methods in terms of various assessment metrics.
Abstract: Imbalanced learning problems contain an unequal distribution of data samples among different classes and pose a challenge to any classifier as it becomes hard to learn the minority class samples. Synthetic oversampling methods address this problem by generating the synthetic minority class samples to balance the distribution between the samples of the majority and minority classes. This paper identifies that most of the existing oversampling methods may generate the wrong synthetic minority samples in some scenarios and make learning tasks harder. To this end, a new method, called Majority Weighted Minority Oversampling TEchnique (MWMOTE), is presented for efficiently handling imbalanced learning problems. MWMOTE first identifies the hard-to-learn informative minority class samples and assigns them weights according to their euclidean distance from the nearest majority class samples. It then generates the synthetic samples from the weighted informative minority class samples using a clustering approach. This is done in such a way that all the generated samples lie inside some minority class cluster. MWMOTE has been evaluated extensively on four artificial and 20 real-world data sets. The simulation results show that our method is better than or comparable with some other existing methods in terms of various assessment metrics, such as geometric mean (G-mean) and area under the receiver operating curve (ROC), usually known as area under curve (AUC).
800 citations
••
Imperial College London1, The Royal Marsden NHS Foundation Trust2, University of Western Australia3, Queensland University of Technology4, St. Vincent's Health System5, University of New South Wales6, Charles University in Prague7, University of Paris8, French Institute of Health and Medical Research9, Max Planck Society10, Ludwig Maximilian University of Munich11, National and Kapodistrian University of Athens12, University of Massachusetts Boston13, University of Hong Kong14, Royal College of Surgeons in Ireland15, University of Palermo16, Kanazawa University17, University of Fukui18, Tokyo Medical and Dental University19, Dokkyo Medical University20, Maastricht University21, Rikshospitalet–Radiumhospitalet22, Tan Tock Seng Hospital23, Autonomous University of Barcelona24, Linköping University25, University of Lausanne26, National Cheng Kung University27, University of Leeds28, University of Edinburgh29, University of Birmingham30, AstraZeneca31, University of Glasgow32, University of Manchester33, Cancer Research UK34, Yale University35, Brown University36, University of Pittsburgh37, Vanderbilt University38, Yeshiva University39, Military Medical Academy40
TL;DR: In this paper, the effect of the Kirsten ras (Ki-ras) tumour genotype and outcome of patients with colorectal cancer was investigated using a multivariate analysis.
Abstract: Researchers worldwide with information about the Kirsten ras (Ki-ras) tumour genotype and outcome of patients with colorectal cancer were invited to provide that data in a schematized format for inclusion in a collaborative database called RASCAL (The Kirsten ras incolorectal-cancer collaborative group). Our results from 2721 such patients have been presented previously and for the first time in any common cancer, showed conclusively that different gene mutations have different impacts on outcome, even when the mutations occur at the same site on the genome. To explore the effect of Ki-ras mutations at different stages of colorectal cancer, more patients were recruited to the database, which was reanalysed when information on 4268 patients from 42 centres in 21 countries had been entered. After predetermined exclusion criteria were applied, data on 3439 patients were entered into a multivariate analysis. This found that of the 12 possible mutations on codons 12 and 13 of Kirsten ras, only one mutation on codon 12, glycine to valine, found in 8.6% of all patients, had a statistically significant impact on failure-free survival (P=0.004, HR 1.3) and overall survival (P=0.008, HR 1.29). This mutation appeared to have a greater impact on outcome in Dukes' C cancers (failure-free survival, P=0.008, HR 1.5, overall survival P=0.02, HR 1.45) than in Dukes' B tumours (failure-free survival, P=0.46, HR 1.12, overall survival P=0.36, HR 1.15). Ki-ras mutations may occur early in the development of pre-cancerous adenomas in the colon and rectum. However, this collaborative study suggests that not only is the presence of a codon 12 glycine to valine mutation important for cancer progression but also that it may predispose to more aggressive biological behaviour in patients with advanced colorectal cancer. ⌐ 2001 Cancer Research Campaign.
753 citations
••
TL;DR: These findings demonstrate unique properties of LPDCs and the importance of TLR5 for adaptive immunity in the intestine and positively regulated the differentiation interleukin 17–producing T helper cells.
Abstract: The intestinal cell types responsible for defense against pathogenic organisms remain incompletely characterized. Here we identify a subset of CD11c(hi)CD11b(hi) lamina propria dendritic cells (LPDCs) that expressed Toll-like receptor 5 (TLR5) in the small intestine. When stimulated by the TLR5 ligand flagellin, TLR5(+) LPDCs induced the differentiation of naive B cells into immunoglobulin A-producing plasma cells by a mechanism independent of gut-associated lymphoid tissue. In addition, by a mechanism dependent on TLR5 stimulation, these LPDCs promoted the differentiation of antigen-specific interleukin 17-producing T helper cells and type 1 T helper cells. Unlike spleen DCs, the LPDCs specifically produced retinoic acid, which, in a dose-dependent way, supported the generation and retention of immunoglobulin A-producing cells in the lamina propria and positively regulated the differentiation interleukin 17-producing T helper cells. Our findings demonstrate unique properties of LPDCs and the importance of TLR5 for adaptive immunity in the intestine.
720 citations
••
University of Pennsylvania1, University of Texas MD Anderson Cancer Center2, University of Marburg3, Memorial Sloan Kettering Cancer Center4, University of Bologna5, Carlos III Health Institute6, University of Maryland, Baltimore7, University of Chicago8, University of Minnesota9, University of Alabama at Birmingham10, Medical University of South Carolina11, University of California, San Francisco12, Thomas Jefferson University13, National Taiwan University14, Yale University15, Centre Hospitalier Universitaire de Toulouse16, University of Fukui17, Seoul National University18, University of Ulsan19, Wake Forest University20, Harvard University21, Astellas Pharma22, Johns Hopkins University23
TL;DR: Gilteritinib resulted in significantly longer survival and higher percentages of patients with remission than salvage chemotherapy among patients with relapsed or refractory FLT3-mutated AML.
Abstract: Background Patients with relapsed or refractory acute myeloid leukemia (AML) with mutations in the FMS-like tyrosine kinase 3 gene (FLT3) infrequently have a response to salvage chemothera...
687 citations
••
Ghent University1, Karolinska Institutet2, Eastern Virginia Medical School3, Université de Montréal4, Katholieke Universiteit Leuven5, Regeneron6, University of Pittsburgh7, University of Barcelona8, University of Pennsylvania9, Brigham and Women's Hospital10, Royal Brisbane and Women's Hospital11, St Thomas' Hospital12, Charité13, Humanitas University14, University of Pisa15, University of South Florida16, University of Amsterdam17, University of Fukui18
TL;DR: Dupilumab significantly improved the coprimary endpoints in both studies and was added to standard of care in adults with severe CRSwNP despite previous treatment with systemic corticosteroids, surgery, or both.
676 citations
Authors
Showing all 4932 results
Name | H-index | Papers | Citations |
---|---|---|---|
Peter Wittich | 139 | 1646 | 102731 |
Julia Thom | 132 | 1441 | 92288 |
R. McNulty | 106 | 1437 | 59110 |
Lucio Cerrito | 106 | 875 | 57563 |
Xin Yao | 103 | 1108 | 53446 |
Shuangyin Wang | 88 | 282 | 26063 |
Norihiro Sadato | 83 | 430 | 24793 |
Yukihiro Ozaki | 82 | 1033 | 32179 |
S. Zucchelli | 79 | 681 | 23612 |
G. P. Yeh | 77 | 682 | 24632 |
Yoshiharu Yonekura | 77 | 482 | 19828 |
Y. Kato | 74 | 741 | 23796 |
Masahiro Hiraoka | 72 | 744 | 22501 |
Haruki Nakamura | 69 | 513 | 19792 |
Jason P. Lerch | 69 | 169 | 21307 |